JNJ-8003
Based on 1 Customer Validation
JNJ-8003 is a potent and orally active non-nucleoside RSV polymerase inhibitor with an IC50 of 0.29 nM. JNJ-8003 targets the L protein polymerase complex of RSV (IC50 = 0.67 nM), and blocks the transcription and replication of the viral genome by inhibiting the activity of RNA-dependent RNA polymerase (RdRp). JNJ-8003 displays subnanomolar activity in vitro as well as prominent efficacy in mice and a neonatal lamb models. JNJ-8003 can be used for the study of respiratory syncytial virus (RSV).
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 99.84%
- CAS 番号: 3118087-68-3
- 分子式: C28H25F5N4O4
- 分子量:576.51
-
保管条件:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
DNA/RNA Synthesis アイソフォーム固有の製品をすべて表示
More
生物活性
|
RNA Polymerase |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HeLa | CC50 |
27.7 μM
Compound: 28; JNJ-8003
|
Cytotoxicity against human HeLa cells measured after 3 days by ATPlite kit assay
Cytotoxicity against human HeLa cells measured after 3 days by ATPlite kit assay
|
[PMID: 39105710] |
JNJ-8003 (5 μM) inhibits RVS RNA replication and transcription at the initiation and early elongation stage[1].
JNJ-8003 exhibits significant anti-RSV activity at the cellular level (HeLa cells) with an EC50 of 0.82 nM and shows cytotoxicity against Hela cells with a CC50 of 27.7 μM[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| Species | Dose | Route | CL | T1/2 | Vdss | Cmax | AUC0-last | F |
|---|---|---|---|---|---|---|---|---|
| Dog[1] | 0.5 mg/kg | i.v. | 5.62 mL/min/kg | 4.25 h | 1.49 L/kg | / | / | / |
| Dog[1] | 0.5 mg/kg | p.o. | / | / | / | 249 ng/mL | 1200 ng·h/mL | 81 % |
| Mice[1] | 10 mg/kg | p.o. | / | / | / | 1727 ng/mL | 9578 ng·h/mL | 61 % |
| Mice[1] | 2.5 mg/kg | i.v. | 10.6 mL/min/kg | 1.95 h | 1.68 L/kg | / | / | / |
| Rat[1] | 1.25 mg/kg | i.v. | 8.03 mL/min/kg | 3.15 h | 1.04 L/kg | / | / | / |
| Rat[1] | 5 mg/kg | p.o. | / | / | / | 401 ng/mL | 2097 ng·h/mL | 20 % |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:RSV-A2 infection model established in 6-8 week old female BALB/c mice (Janvier)[2]
-
Dosage:1, 4, 10, 40, 100 mg/kg
-
Administration:Oral administration (p.o.), once daily for 4 days
-
Result:Dose-dependently inhibited virus, with viral titers dropping below the detection limit at doses of 10 mg/kg and above.
-
Animal Model:RSV M37 infection model established in lamb (from LambCure)[2]
-
Dosage:0.25, 1, 4 mg/kg
-
Administration:Oral administration (p.o.), once daily for 5 days
-
Result:Decreased the lung virus titer below the detection limit at 4 mg/kg.
Completed resolution of lung inflammation and lesions (H&E scores returned to normal).
化学情報
-
CAS 番号 3118087-68-3
-
性状 Solid
-
分子量 576.51
-
分子式 C28H25F5N4O4
-
Color Off-white to light yellow
-
SMILES
CC(N=N1)=CC2=C1C(OC)=CC(C(NC[C@](C(F)(F)F)(O)C3=CC(C(C)(C)O)=C(F)C(C4=CC=C(F)C=C4)=N3)=O)=C2
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
溶剤 & 溶解度
DMSO : 125 mg/mL (216.82 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
純度とドキュメンテーション
-
データシート (277 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
取扱説明書 (2659 KB)
参考文献
[1]. Yu X, et al. Structural and mechanistic insights into the inhibition of respiratory syncytial virus polymerase by a non-nucleoside inhibitor. Commun Biol. 2023 Oct 21;6(1):1074. [Content Brief]
[2]. Grosse S, et al. Discovery of gem-Dimethyl-hydroxymethylpyridine Derivatives as Potent Non-nucleoside RSV Polymerase Inhibitors. J Med Chem. 2024 Aug 22;67(16):13723-13736. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.7346 mL | 8.6729 mL | 17.3458 mL | 43.3644 mL |
| 5 mM | 0.3469 mL | 1.7346 mL | 3.4692 mL | 8.6729 mL | |
| 10 mM | 0.1735 mL | 0.8673 mL | 1.7346 mL | 4.3364 mL | |
| 15 mM | 0.1156 mL | 0.5782 mL | 1.1564 mL | 2.8910 mL | |
| 20 mM | 0.0867 mL | 0.4336 mL | 0.8673 mL | 2.1682 mL | |
| 25 mM | 0.0694 mL | 0.3469 mL | 0.6938 mL | 1.7346 mL | |
| 30 mM | 0.0578 mL | 0.2891 mL | 0.5782 mL | 1.4455 mL | |
| 40 mM | 0.0434 mL | 0.2168 mL | 0.4336 mL | 1.0841 mL | |
| 50 mM | 0.0347 mL | 0.1735 mL | 0.3469 mL | 0.8673 mL | |
| 60 mM | 0.0289 mL | 0.1445 mL | 0.2891 mL | 0.7227 mL | |
| 80 mM | 0.0217 mL | 0.1084 mL | 0.2168 mL | 0.5421 mL | |
| 100 mM | 0.0173 mL | 0.0867 mL | 0.1735 mL | 0.4336 mL |